Tech Company Financing Transactions

Sensei Biotherapeutics Funding Round

Sensei Biotherapeutics closed a $28.5 million venture capital round on 10/13/2020. Investors included Cambrian Ventures, H&S Ventures and Apeiron Holdings.

Transaction Overview

Announced On
10/13/2020
Transaction Type
Venture Equity
Amount
$28,500,000
Round
Undisclosed
Investors

Cambrian Ventures (Lead Investor)

H&S Ventures (Lead Investor)

Apeiron Holdings

Future Ventures

Proceeds Purpose
Sensei will use some of the money to expand development of SNS-301, a bacteriophage engineered to express a fusion protein of native bacteriophage GPD protein and a selected domain of aspartate ß-hydroxylase (ASPH).

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1405 Research Blvd. 125
Rockville, MD 20850
USA
Email Address
Overview
Sensei Biotherapeutics is a clinical-stage biotechnology company developing novel biologics therapies targeting key components of the immune system for the treatment of cancers of unmet need. Driven by innovative science, world class scientists, and an entrepreneurial culture.
Profile
Sensei Biotherapeutics LinkedIn Company Profile
Social Media
Sensei Biotherapeutics Company Twitter Account
Company News
Sensei Biotherapeutics News
Facebook
Sensei Biotherapeutics on Facebook
YouTube
Sensei Biotherapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Celebi
  John Celebi LinkedIn Profile  John Celebi Twitter Account  John Celebi News  John Celebi on Facebook
Chief Medical Officer
Marie Fjaellskog
  Marie Fjaellskog LinkedIn Profile  Marie Fjaellskog Twitter Account  Marie Fjaellskog News  Marie Fjaellskog on Facebook
Chief Scientific Officer
Robert Pierce
  Robert Pierce LinkedIn Profile  Robert Pierce Twitter Account  Robert Pierce News  Robert Pierce on Facebook
Vice President
Jean Campbell
  Jean Campbell LinkedIn Profile  Jean Campbell Twitter Account  Jean Campbell News  Jean Campbell on Facebook
Vice President
Edward van der Horst
  Edward van der Horst LinkedIn Profile  Edward van der Horst Twitter Account  Edward van der Horst News  Edward van der Horst on Facebook
VP - Finance
Erin Colgan
  Erin Colgan LinkedIn Profile  Erin Colgan Twitter Account  Erin Colgan News  Erin Colgan on Facebook
VP - Operations
Pauline Callinan
  Pauline Callinan LinkedIn Profile  Pauline Callinan Twitter Account  Pauline Callinan News  Pauline Callinan on Facebook
VP - Operations
Alice Drumheller
  Alice Drumheller LinkedIn Profile  Alice Drumheller Twitter Account  Alice Drumheller News  Alice Drumheller on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/13/2020: YotaScale venture capital transaction
Next: 10/13/2020: Clair venture capital transaction

 

Share this article

 


Where The Data Comes From

We record every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary